GB9911453D0 - Benzofuranylaminoalcohols - Google Patents
BenzofuranylaminoalcoholsInfo
- Publication number
- GB9911453D0 GB9911453D0 GBGB9911453.0A GB9911453A GB9911453D0 GB 9911453 D0 GB9911453 D0 GB 9911453D0 GB 9911453 A GB9911453 A GB 9911453A GB 9911453 D0 GB9911453 D0 GB 9911453D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- benzofuranylaminoalcohols
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9911453A GB2350110A (en) | 1999-05-17 | 1999-05-17 | Pharmaceutically active benzofurans |
PCT/EP2000/004015 WO2000069841A2 (en) | 1999-05-17 | 2000-05-04 | Benzofuranylaminoalcohols |
AU45616/00A AU4561600A (en) | 1999-05-17 | 2000-05-04 | Benzofuranylaminoalcohols |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9911453A GB2350110A (en) | 1999-05-17 | 1999-05-17 | Pharmaceutically active benzofurans |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9911453D0 true GB9911453D0 (en) | 1999-07-14 |
GB2350110A GB2350110A (en) | 2000-11-22 |
Family
ID=10853621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9911453A Withdrawn GB2350110A (en) | 1999-05-17 | 1999-05-17 | Pharmaceutically active benzofurans |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4561600A (en) |
GB (1) | GB2350110A (en) |
WO (1) | WO2000069841A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7153871B2 (en) | 2001-01-22 | 2006-12-26 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
US7144885B2 (en) | 2002-02-22 | 2006-12-05 | Bayer Pharmaceuticals Corporation | Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
CA2474511C (en) | 2002-02-22 | 2008-07-22 | Bayer Pharmaceuticals Corporation | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
AU2003256601B2 (en) * | 2002-07-19 | 2009-10-29 | Memory Pharmaceuticals Corporation | 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
RU2368604C2 (en) | 2002-07-19 | 2009-09-27 | Мемори Фармасьютиклз Корпорейшн | Phosphodiestarase 4 inhibitors, containing n-substituted aniline and diphenylamine analogues |
BR0315705A (en) | 2002-11-19 | 2005-09-06 | Memory Pharm Corp | Phosphodiesterase-4 Inhibitors |
US9856263B2 (en) | 2014-04-28 | 2018-01-02 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine D1 ligands |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4056626A (en) * | 1971-05-13 | 1977-11-01 | Kakenyaku Kako Co., Ltd. | Pharmaceutical composition containing benzofuran derivative |
EP0146243A1 (en) * | 1983-10-31 | 1985-06-26 | Merck Frosst Canada Inc. | Lipoxygenase inhibitors |
GB9504460D0 (en) * | 1995-03-06 | 1995-04-26 | Bayer Ag | N-(3-Benzofuranyl)urea-derivatives |
GB9525262D0 (en) * | 1995-12-11 | 1996-02-07 | Bayer Ag | Heterocyclylcarbonyl substituted benzofuranyl-ureas |
GB9614718D0 (en) * | 1996-07-12 | 1996-09-04 | Bayer Ag | 3-ureido-pyridofurans and -pyridothiophenes |
-
1999
- 1999-05-17 GB GB9911453A patent/GB2350110A/en not_active Withdrawn
-
2000
- 2000-05-04 AU AU45616/00A patent/AU4561600A/en not_active Abandoned
- 2000-05-04 WO PCT/EP2000/004015 patent/WO2000069841A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB2350110A (en) | 2000-11-22 |
WO2000069841A2 (en) | 2000-11-23 |
WO2000069841A3 (en) | 2002-05-02 |
AU4561600A (en) | 2000-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60018571D1 (en) | Hernienprothese | |
DE60033307D1 (en) | Heteroalkylamino-substituierte bicyclische stickstoffheterocyclen | |
DE60008112D1 (en) | Respiratorisches syncytialvirus replikation inhibitoren | |
DE60037335D1 (en) | Polymerizationsverfahren | |
DE50002490D1 (en) | Polyester-polyetherblockcopolymere | |
DE60008382D1 (en) | Respiratorisches syncytialvirus replikation inhibitoren | |
DE50008011D1 (en) | Thixotropierungsmittel | |
DE60018288D1 (en) | Polyphenylensulfidlegierungszusammensetzung | |
DE60027722D1 (en) | Aspartyl-protease inhibitoren | |
DE50002614D1 (en) | Sigma-delta-modulator | |
DE60034237D1 (en) | Ferrofluidabdichtung | |
DE60007505D1 (en) | Propargyletherderivate | |
DE60028360D1 (en) | Ptk-chipthermistor | |
DE60036727D1 (en) | Differentialverstärker | |
DE50000137D1 (en) | Spirofluorenopyrane | |
DE60011809D1 (en) | Oxcarbazepinsuspension | |
DE59909975D1 (en) | Testleck | |
DE10081629D2 (en) | Seilzugbefestigung | |
DE60001313D1 (en) | Imidazodiazepinderivate | |
DE50009469D1 (en) | Common-rail-injektor | |
DE60012950D1 (en) | Polyacetalharzzusammensetzung | |
DE60044740D1 (en) | Hochtemperatur-differentialrefraktometer | |
DE50010757D1 (en) | Stilbenaufheller | |
DE60037536D1 (en) | Polypeptidhormon phosphatonin | |
DE50008218D1 (en) | Common-rail-injektor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |